CAPTRUST Financial Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,990
Closed -$135K 4206
2022
Q2
$135K Sell
1,990
-224
-10% -$16.1K ﹤0.01% 1990
2022
Q1
$201K Buy
2,214
+2,096
+1,776% +$172K ﹤0.01% 1724
2021
Q4
$11K Buy
118
+100
+556% +$8.57K ﹤0.01% 3672
2021
Q3
$1K Sell
18
-104
-85% -$8.74K ﹤0.01% 4513
2021
Q2
$11K Buy
122
+4
+3% +$388 ﹤0.01% 3512
2021
Q1
$13K Buy
+118
New +$12.2K ﹤0.01% 3302

Other funds holding NARI

CAPTRUST Financial Advisors's NARI Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2022, closing a stake of 1,990 shares — an estimated $135K sold.

CAPTRUST Financial Advisors first reported a position in NARI in Q1 2021 and held it in 6 quarters. The position peaked at $201K in Q1 2022. 240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,990 Inari Medical, Inc. Common Stock shares in Q3 2022, an estimated $135K.
  • CAPTRUST Financial Advisors first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Inari Medical, Inc. Common Stock position peaked at $201K in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.